aortic diseases
DESCRIPTION
Aortic Diseases. Elliot L. Chaikof, MD, PhD Roberta and Stephen R. Weiner Department of Surgery Beth Israel Deaconess Medical Center Harvard Medical School. Clinical Practice Council of the SVS. AAA Practice Guidelines Writing Committee. Elliot L. Chaikof, MD, PhD - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/1.jpg)
Aortic Diseases
Elliot L. Chaikof, MD, PhDRoberta and Stephen R. Weiner Department of Surgery
Beth Israel Deaconess Medical Center Harvard Medical School
![Page 2: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/2.jpg)
Elliot L. Chaikof, MD, PhD David C. Brewster, MDRonald L. Dalman, MDMichel S. Makaroun, MDKarl A. Illig, MDGregorio A. Sicard, MDCarlos H. Timaran, MD Gilbert R. Upchurch, Jr., MD Frank J. Veith, MD
Clinical Practice Council of the SVS
AAA Practice Guidelines Writing
Committee
![Page 3: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/3.jpg)
Prevalence of Aortic Aneurysm
• Prevalence of AAA among women is slowly increasing, with women now representing 1/3 of patients presenting with rupture.
![Page 4: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/4.jpg)
Circulation 2011; 124:1118-1123
AAA (> 3 cm) in 1.7% of 26,000 65 y/o men screened
![Page 5: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/5.jpg)
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
1993 1995 1997 1999 2001 2003 2005
EVAR
TOTAL OPEN
Annual Open AAA and EVAR in US: 1993 - 2005
Schermerhorn M et al. JVS 2009; 49(3):543-50
![Page 6: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/6.jpg)
Lancet 2002; 360: 1531–39
Community-based screening reduces mortality from an AAA in men aged 65–79 years, but are not cost effective in women in whom the prevalence of AAAs is lower
![Page 7: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/7.jpg)
Jonk YC, Kane RL, Lederle FA, MacDonald R, Cutting AH, Wilt TJ.Int J Technol Assess Health Care 2007;23:205-15.
All Markov modeling studies published to date have predicted higher lifetime costs associated with EVAR
![Page 8: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/8.jpg)
SVS Clinical Decisions for Patients with Aortic Disease
1. Comparative effectiveness of OR vs EVAR• Ascending and arch aortic aneurysms• Thoracoabdominal aneurysms• Acute or Chronic Type B aortic dissections
2. Optimal treatment of AAA between 5 – 6 cm
3. Optimal surveillance regimens after EVAR
![Page 9: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/9.jpg)
$7,300 per capita in US in 2008Bending the cost curve
Reduce Per Capita Costs
Reduce Unnecessary Interventions
• Selective screening and surveillance• Selective repair• Reducing costs for EVAR or OSR
![Page 10: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/10.jpg)
Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act 2006
• A one-time AAA US screening as part of a Welcome to Medicare physical exam.
• The physical must be conducted during the first 12 months of enrollment.
Who qualifies for the Medicare screening? • Men who have smoked sometime during their life• Men and women with a family history of AAA
In 2009, 20,000 Medicare patients were screened out of 200,000 in the US at risk
![Page 11: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/11.jpg)
Risk Factors for Aortic Aneurysms• Smoking is the single strongest risk
factor for the development of AAA• AAA risk increases by 40% every 5
years after the age of 65 years • Men are at much higher risk of AAA
than women• Central obesity increases risk• A family history of AAA doubles the
risk of AAA
![Page 12: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/12.jpg)
Risk factors for aortic aneurysms do not correlate with many risk factors for atherosclerosis -
• Hypertension is weakly associated with AAA
• The relationship between hyperlipidemia and AAA is complex
• Diabetes is protective of AAA formation
![Page 13: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/13.jpg)
Nat. Genet. 40, 217–224 (2008)
Nat. Genet. 42, 692–697 (2010)
![Page 14: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/14.jpg)
Who do we screen?
Ann Intern Med. 2005;142:203-211
J Vasc Surg 2005;41:741-51
British Medical J 2004; 329: 1259-1262
• Selective screening of high risk groups
• Risk factor scores
![Page 15: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/15.jpg)
Who should be enrolled in continued AAA
SurveillanceShould we follow aneurysms less than 4 cm in diameter given their low risk of rupture?
![Page 16: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/16.jpg)
• 12 yr analysis of 1121 AAA in 65 yr-old men • 2.6 cm < AAA < 2.9 cm
• 14% > 5.4 cm at 10 years
• 3.5 cm < AAA < 3.9 cm • 10.5% > 5.4 cm and 1.4% had
ruptured at 2 years
Br J Surg 90: 821-6, 2003
![Page 17: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/17.jpg)
Biomarkers for AAA Disease
![Page 18: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/18.jpg)
Has the balance of risk and benefit changed with EVAR?
Immediate EVAR vs. Surveillance4.0 cm < AAA < 5.4 cm
Management of the Small AAA
![Page 19: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/19.jpg)
360 patients
180 pts EVAR 180 pts SurveillanceMean f/u 26 mos.
236 pts EVAR 15 pts OSR 102 pts Surv.
• Aneurysm-related mortality (0.6% vs 0.6%; p=1)
• 30-day mortality (1% vs 0%; p=1)
• Aneurysm rupture (0% vs 0.2%; p=0.2)
CAESAR Small AAA Trial: Immediate EVAR vs. Surveillance
![Page 20: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/20.jpg)
• 76/180 (42%) patients in the surveillance group underwent repair
• The probability of receiving AAA repair over a 3-yr study interval was
• > 50% > 4.5 cm
• 32/180 (18%) underwent open surgery because of loss of EVAR suitability
CAESAR Trial at 3 Years: Immediate EVAR vs. Surveillance
![Page 21: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/21.jpg)
Crossover Effect in Trials of AAA Treatment vs
Observation• UK SAT: 62% (327/527) crossed
over during a 5-year follow-up period.
• ADAM: 62% (351/567) crossed over during a 5-year follow-up period.
• Crossovers related to subjective ‘symptoms’ or patient preference.
![Page 22: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/22.jpg)
Patient Perspective with a Small AAAThe question is not…
“if” EVAR should be performed but “when”…
![Page 23: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/23.jpg)
Pharmacological Strategies to Prevent AAA Expansion or Rupture• b-blockers and ACE inhibitors• Tetracycline and macrolide antibiotics• Anti-platelet agents• Statins
J Vasc Surg 2002; 36: 1-12
The Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA3CT)NIH Funded Trial - Randomize 248 patients
Determine if doxycycline (100 mg bid) will inhibit by 40% the increase in diameter of small AAA (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period.
![Page 24: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/24.jpg)
Clinical Trials to Assess Risk and the Benefit of Medical Intervention
• Inflammation and Risk Prediction in Patients With AAA (Vanderbilt, PI: U. Sampson )– predicting risk using FDG-PET with CT
• Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension (VU University, PI: Jan D. Blankensteijn)– Aliskiren and Amlodipine
![Page 25: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/25.jpg)
• Evaluation of Effect of ACE Inhibitors (perindopril) on Small Aneurysm Growth Rate – (Imperial College, PI: Neil R Poulter)
• Feasibility Study of Exercise Training for AAA Disease – (Sheffield Teaching Hospitals/University
of Hull)
Clinical Trials to Assess Risk and the Benefit of Medical Intervention
![Page 26: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/26.jpg)
Morbidity of Open and EVAR AAA Repairs: 1995 - 2008
Schermerhorn M et al. NEJM 2008; 358:464-474.
![Page 27: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/27.jpg)
• Risk models that incorporate physiological and anatomical data (APACHE II, GAS, POSSUM).
• Improved tools to assess likelihood of aneurysm expansion and rupture risk among high risk patients.
• Interventions to reduce postoperative morbidity (e.g. cardiac, pulmonary, renal)
Risk Models for Elective EVAR or Open AAA Repair
![Page 28: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/28.jpg)
N Engl J Med 2007;357:2277-84
Number of CT scans/yr in US
Lifetime Cancer Risk/Abdominal CTDoubling in less than a decade
![Page 29: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/29.jpg)
J Vasc Surg 2009;49:60-5
• 406 paired CT/US examinations• Sensitivity for Duplex ultrasound was 86%• All clinically significant endoleaks demonstrated
on CTA were also detected on Duplex ultrasound
![Page 30: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/30.jpg)
• Contrast Ultrasound in the Surveillance of EVAR (n = 160)– Ottawa Hospital Research Institute, PI:
Sudhir Nagpal
• CT Versus Color Duplex US for Surveillance of EVAR. A Prospective Multicenter Study (n = 1000)– Centre Hospitalier Universitaire de Nice,
PI: Hassen-Khofja Reda
US vs CTA for Surveillance After EVAR
![Page 31: Aortic Diseases](https://reader034.vdocuments.net/reader034/viewer/2022051218/56815c71550346895dca84ec/html5/thumbnails/31.jpg)